Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. (Q37125932)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

5 January 2020

2

Hutan Ashrafian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

5 January 2020

1

Royce P Vincent

1 reference

5 January 2020

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

language of work or name

English

0 references

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

5 January 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

5 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

268-277

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18382432 AND SRC:MED&resulttype=core&format=json

Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

Human distribution and release of a putative new gut hormone, peptide YY

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

Evidence for a cholecystokinin gut-brain axis with modulation by bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Neuropeptide Y (NPY) Y4 receptor selective agonists based on NPY(32-36): development of an anorectic Y4 receptor selective agonist with picomolar affinity

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Obesity wars: molecular progress confronts an expanding epidemic

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Is the energy homeostasis system inherently biased toward weight gain?

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Changes in Energy Expenditure Resulting from Altered Body Weight

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Cholecystokinin decreases food intake in rats.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Gut hormones and the regulation of energy homeostasis

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

A role for ghrelin in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin action in the brain controls adipocyte metabolism

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin stimulates insulin-induced glucose uptake in adipocytes.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin increases food intake in obese as well as lean subjects

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Mice lacking ghrelin receptors resist the development of diet-induced obesity

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Absence of ghrelin protects against early-onset obesity

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effects of obestatin on energy balance and growth hormone secretion in rodents

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

GPR39 signaling is stimulated by zinc ions but not by obestatin

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

GPR39 receptor expression in the mouse brain

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)?

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Pancreatic polypeptide reduces appetite and food intake in humans

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Distribution of pancreatic polypeptide receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Decreased food intake and body weight in pancreatic polypeptide-overexpressing mice

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peptides of the gut and brain: the cholecystokinins

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Cholecystokinin and satiety: current perspectives

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Lithium chloride, cholecystokinin and meal patterns: evidence that cholecystokinin suppresses meal size in rats without causing malaise

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Gut endocrine secretions and their relevance to satiety

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Rapid development of tolerance to the behavioural actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Biology of incretins: GLP-1 and GIP

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Gastric inhibitory polypeptide (GIP) and insulin in obesity: Increased response to stimulation and defective feedback control of serum levels

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

On the physiology of GIP and GLP-1.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Central Administration of Glucagon-Like Peptide-1 Activates Hypothalamic Neuroendocrine Neurons in the Rat*

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Glucagon-like peptide-1 7-36: a physiological incretin in man.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Glucagon-like peptide-1: a potent regulator of food intake in humans

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

A role for glucagon-like peptide-1 in the central regulation of feeding

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

A role for central glucagon-like peptide-1 in temperature regulation

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Lipolytic action of glucagon-like peptides in isolated rat adipocytes

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effect of GLP-1 on lipid metabolism in human adipocytes.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Oxyntomodulin suppresses appetite and reduces food intake in humans

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peripheral oxyntomodulin reduces food intake and body weight gain in rats.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effects of peptide YY and neuropeptide Y on gastric emptying in man

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Attenuated peptide YY release in obese subjects is associated with reduced satiety.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effect of peptide YY3-36 on food intake in humans

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Critical role for peptide YY in protein-mediated satiation and body-weight regulation

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Untangling the effects of hunger, anxiety, and nausea on energy intake during intravenous cholecystokinin octapeptide (CCK-8) infusion

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peptide YY abnormalities in gastrointestinal diseases

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021

Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively

1 reference

https://api.crossref.org/works/10.1038/NCPGASTHEP1118

7 January 2021